Jared Holz, Mizuho Securities health care strategist, joins 'Fast Money' to discuss Eli Lilly's biggest day drop since 2008 ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing, and Lilly CEO David Ricks has personally met with President Donald Trump in ...

A Tampa family celebrated their daughter's health milestone at the March of Dimes March for Babies walk. Lilly Lewellen spent ...

Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

Navigating ineffective weight management treatment is a sensitive process that requires acknowledgement of bias from both ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

NHS to trial prescribing the appetite-supressing drugs after a short consultation at a high street pharmacy as Government ...

In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

After going after the companies making compounded versions of their drugs, GLP-1 makers are now going into business with the ...

Health service to make medications Mounjaro and Wegovy available after short consultation as part of war on obesity ...